Chromosome Aberration Reference Info
Ref. No
12410
Title
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia.
Authors
Journal
Volume
111:1834-1839
Year
2008